All
Research
Education
Исследования
Образование
Business
Решения
RU
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Войдите в систему
Oncology R&D group
Jonathon Golas has not added Biography.
If you are Jonathon Golas and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Oncotarget Feb, 2015 | Pubmed ID: 25671303
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Proceedings of the National Academy of Sciences of the United States of America 12, 2018 | Pubmed ID: 30487219
Pfizer Worldwide Research and Development
Shuang Chen1,
Andreas Giannakou1,
Jonathon Golas1,
Kenneth G. Geles1
1Oncology R&D group, Pfizer Worldwide Research and Development
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены
